The Scientist

» biosimilars

Most Recent

image: TS Picks: September 8, 2015

TS Picks: September 8, 2015

By | September 8, 2015

Pharma edition

0 Comments

image: FDA OKs First Biosimilar

FDA OKs First Biosimilar

By | March 6, 2015

The US Food and Drug Administration approves Sandoz’s Zarxio, a biosimilar to Amgen’s filgrastim, which is mainly prescribed for cancer patients.

2 Comments

image: Pfizer to Acquire Hospira

Pfizer to Acquire Hospira

By | February 5, 2015

The pharmaceutical giant is purchasing the injectable drugmaker for about $15 billion.

0 Comments

image: Obamacare Will Affect Research

Obamacare Will Affect Research

By | June 29, 2012

The Supreme Court's decision to uphold President Barack Obama's health care reform law contains key provisions that will impact US science funding in the years to come.

28 Comments

image: Regulations for Biosimilars

Regulations for Biosimilars

By | June 1, 2012

As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?

2 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech